GL Pharm Tech Corp. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported negative sales was KRW 0.00037 million compared to sales of KRW 0.00038 million a year ago.

Net loss was KRW 598.2 million compared to KRW 2,185.28 million a year ago. Basic loss per share from continuing operations was KRW 10 compared to KRW 42 a year ago. Diluted loss per share from continuing operations was KRW 10.

Basic loss per share was KRW 10 compared to KRW 42 a year ago.